BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3539676)

  • 1. Influence of age on responsiveness to diabetogenic action of growth hormone.
    Cameron CM; Kostyo JL
    Diabetes; 1987 Jan; 36(1):88-92. PubMed ID: 3539676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetogenic activity of native and biosynthetic human growth hormone in obese (ob/ob) mouse.
    Kostyo JL; Gennick SE; Sauder SE
    Am J Physiol; 1984 Apr; 246(4 Pt 1):E356-60. PubMed ID: 6720889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
    Towns R; Kostyo JL; Colca JR
    Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cycloheximide on acute diabetogenic effects of S-carboxymethylated human growth hormone in obese (ob/ob) mice.
    Adamafio NA; Cameron CM; Kostyo JL
    Horm Metab Res; 1988 Jul; 20(7):391-4. PubMed ID: 3049288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of S-carboxymethylated human growth hormone on insulin resistance in the obese (ob/ob) mouse.
    Adamafio NA; Kostyo JL; Cameron CM; Trimark JR; Dunbar JC
    Metabolism; 1988 Sep; 37(9):900-5. PubMed ID: 3047525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
    Salem MA; Wolff GL
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
    Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
    Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth factor from plerocercoid larvae of the tapeworm, Spirometra mansonoides, stimulates growth but is not diabetogenic.
    Salem MA; Phares CK
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):187-92. PubMed ID: 2726784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
    Ader M; Agajanian T; Finegood DT; Bergman RN
    Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmammalian growth hormones have diabetogenic and insulin-like activities.
    Cameron CM; Kostyo JL; Papkoff H
    Endocrinology; 1985 Apr; 116(4):1501-5. PubMed ID: 3882411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stimulatory effect of insulin on diacylglycerol generation in adipocyte membranes from ob/ob mice is impaired by growth hormone.
    Towns R; Kostyo JL; Martin D; Chou SY; Bennink MR
    Endocrinology; 1993 Apr; 132(4):1671-6. PubMed ID: 8462467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities.
    Kostyo JL; Cameron CM; Olson KC; Jones AJ; Pai RC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4250-3. PubMed ID: 3889926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced and S-carboxymethylated human growth hormone: a probe for diabetogenic action.
    Cameron CM; Kostyo JL; Rillema JA; Gennick SE
    Am J Physiol; 1984 Nov; 247(5 Pt 1):E639-44. PubMed ID: 6496734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
    Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
    Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man.
    Abrams RL; Grumbach MM; Kaplan SL
    J Clin Invest; 1971 Apr; 50(4):940-50. PubMed ID: 4926262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ
    Horm Metab Res; 1981 Oct; 13(10):556-60. PubMed ID: 7028589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age and endogenously secreted human growth hormone on the regulation of gonadotropin secretion in female and male transgenic mice expressing the human growth hormone gene.
    Chandrashekar V; Bartke A
    Endocrinology; 1993 Apr; 132(4):1482-8. PubMed ID: 8462447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site.
    Rosenfeld RG; Wilson DM; Dollar LA; Bennett A; Hintz RL
    J Clin Endocrinol Metab; 1982 May; 54(5):1033-8. PubMed ID: 7037819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and growth hormone in lean and obese pigs.
    Wangsness PJ; Martin RJ; Gahagan JH
    Am J Physiol; 1977 Aug; 233(2):E104-8. PubMed ID: 888946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.